Inizio has announced a significant expansion of its Global Medical Information capabilities through Inizio Engage, introducing Connected Insights to help pharmaceutical and biotechnology companies transform Medical Information from a responsive support function into a strategic source of intelligence.
Combining expanded Asia-Pacific (APAC) expertise, enhanced global infrastructure and AI-enabled innovation, the investment enables organisations to generate actionable insights from every scientific interaction while delivering consistent, high-quality Medical Information at global scale.
As therapies become increasingly specialised and scientific engagement grows more complex, Medical Information teams are expected to do far more than answer inquiries. Organisations are looking to identify emerging trends, better understand healthcare professional and patient needs, and generate insights that strengthen Medical Affairs strategy, all while maintaining scientific accuracy, regulatory compliance and exceptional customer experiences. Connected Insights ensures the value of every Medical Information interaction extends beyond the individual inquiry, turning real-world engagement data into actionable intelligence that informs strategy, uncovers opportunities and creates value across a client’s entire portfolio.
“Medical Information has become one of the richest sources of scientific insight across the product life cycle,” said Jenny Reid-Young, Vice President, Global Medical Information of Inizio Engage. “Organisations that can connect those interactions across markets and translate them into meaningful intelligence will make better decisions, improve customer experiences and strengthen Medical Affairs strategy.”
Designed to support organisations operating across global and regional markets, Inizio Engage delivers Medical Information programmes in more than 20 languages, combining the simplicity of a single global partner with deep local expertise.
Amy Van Sant, Global President, Medical Affairs at Inizio Engage, added: “By combining scientific expertise with AI-enabled capabilities and global scale, we’re helping clients unlock significantly more value from every interaction and redefine what’s possible through Global Medical Information.”